Latest Updates

Recognition is for Quintiles’ contribution to vaccines drug development

As Eppendorf India completes a decade of direct operation in India, the company thanks customers, distributors, suppliers, media…

The platform is an offering from ForteBio Division of Pall India and it enables label-free analyses of proteins using small sample…

IPA Convention 2013 gets overwhelming response from pharma industry across India

Workshop scheduled for April 27 & 28; preceding patent agent exam on May 4th & 5th

Company’s will assign IP pertaining to a lead antibiotic compound

It reveals increasing complexity in applications received, growth in companies with SME status, and other trends

It is launched under the brand name ETACEPT, to treat rheumatic disorders

Dedicated Specific Pathogen Free (SPF) facility meets the new regulatory requirements of developed countries including Brazil,…

AYUSH industry will showcase its formulations to global pharma regulators